<<

Name, Title: Ulrik Ringborg, Professor Function within OECI: President Education ▪ Degrees: MD/PhD ▪ Specialization: Medical oncology/Radiation therapy

Professional Experience ▪ PhD 1971

▪ Med. Lic. degree and State registration as medical practitioner 1972.

▪ Associate Professor of General Oncology 1978, qualifying as an oncology specialist 1979. Consultant, Department of General Oncology, , 1987.

▪ Senior Consultant, Department of General Oncology, Radiumhemmet, 1992.

▪ Professor of Oncology, , 1992, and Head of the Department of Oncology, Karolinska Hospital, 1992.

▪ 1993-96 Prefect, Institute of Oncology-Pathology.

▪ Since 1994 Director Cancer Center Karolinska.

▪ 1995-2003 Head Division of Oncology, Karolinska Hospital.

▪ 1996-2003 Member of the Executive Group of the Karolinska Hospital.

▪ 2004-2005 Head of the Oncologic Clinic of the new Karolinska Hospital

▪ Present position: Senior physician, Professor of Oncology, Director of the Cancer Center Karolinska.

▪ Special mission: To coordinate the formation of a Comprehensive Cancer Center of all cancer activities at the Karolinska University Hospital and the Karolinska Institute.

Special Recognition: ▪ Main areas of research interest: Malignant melanoma

Various appointments: Chairman of the Swedish Melanoma Study Group 1976- 2003,

Member of the Research Board and the Governing Body of the Cancer Society.

Member of the Research Board and the Governing Body of the King Gustaf V Jubilee Fund.

Member of the Nobel Assembly.

Member of the Research Board and the Governing Body (Vice Chairman) of the Swedish Cancer Society.

Member of the Scientific Advisory Committee of EORTC.

Member of the Steering Group of NOCI, EORTC

President of the European Society of Skin Cancer Prevention (2002-2003).

Chairman of the Advisory Board for UV-protection, Swedish Radiation Protection Authority.

Member of the Board of ECCO.

Honorary member, the Radiological Society of North America.

Honorary member, the Hungarian Cancer Society

Publications: 273 publications in international journals and books, scientific focus on malignant melanoma.